1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
| Species | Human |
| Cat.No | ABL-TC0611 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Tongue |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Tongue Cancer Cell Lines |
SAS is a human tongue squamous cell carcinoma cell line that was originally isolated from a primary tumor of a patient with tongue cancer. SAS exhibits epithelial-like morphology and adherent culture properties. SAS is tumorigenic. Studies have shown that this cell line is associated with oral squamous cell carcinoma (OSCC) and head and neck cancer.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
SAS cells enable research in tongue cancer biology, including tumor growth, invasion, metastasis, and therapeutic responses. They support efficacy assessments of platinum-based agents, taxanes, and valproic acid using xenograft models, preclinical drug screening, and in vivo studies of tumor behavior and microenvironment interactions. These cells facilitate CDX model development for tumor intervention studies, mechanistic exploration of cancer progression, translational research bridging basic and clinical science, and immunotherapy investigations.
